新医学2011，Vol.42Issue(12)：786-788,3.DOI:10.3969/g.issn.0253-9802.2011.12.007
地西他滨治疗骨髓增生异常综合征10例疗效观察
Curative effect of decitabine in 10 cases with myelodysplastic syndrome
范蕊芳 1刘相富 1方志刚 1郑永江 1林东军1
作者信息
- 1. 中山大学附属第三医院血液科 510630
- 折叠
摘要
Abstract
Objective; To evaluate the curative effect and adverse effect of decitabine in the treatment of myel-odysplastic syndrome (MDS). Methods; A total of 10 patients with MDS were retrospectively analyzed. We used decitabine 25 mg /d x 5 d as the regimen, and evaluated after two course of treatment Results; Three patients died after the first course thus their data couldn't be evaluated. Three patients showed complete remission, one patient hematologic improvement, one stable condition. Conclusion ? Decitabine is effective for the intermediate 2 and high-risk myelodysplastic syndrome.关键词
骨髓增生异常综合征/地西他滨/疗效Key words
Myelodysplastic syndrome/ Decitabine/ Effectiveness引用本文复制引用
范蕊芳,刘相富,方志刚,郑永江,林东军..地西他滨治疗骨髓增生异常综合征10例疗效观察[J].新医学,2011,42(12):786-788,3.
